TOMASELLO, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 316
EU - Europa 266
AS - Asia 150
AF - Africa 6
Totale 738
Nazione #
US - Stati Uniti d'America 308
CN - Cina 88
IE - Irlanda 83
SE - Svezia 76
SG - Singapore 52
IT - Italia 36
FI - Finlandia 35
DE - Germania 17
CA - Canada 8
CI - Costa d'Avorio 6
BE - Belgio 5
FR - Francia 5
TR - Turchia 5
CZ - Repubblica Ceca 3
IN - India 3
IR - Iran 2
RU - Federazione Russa 2
GB - Regno Unito 1
LT - Lituania 1
NL - Olanda 1
UA - Ucraina 1
Totale 738
Città #
Chandler 90
Dublin 83
Singapore 44
New York 30
Shanghai 22
Ann Arbor 21
Ashburn 18
Boardman 18
Dearborn 17
Parma 16
Princeton 13
Nanjing 11
Beijing 9
Helsinki 8
Abidjan 6
Bremen 6
Jinan 6
Brussels 5
Izmir 5
Seattle 5
Toronto 5
Santa Clara 4
Wilmington 4
Changsha 3
Hebei 3
Hefei 3
Nanchang 3
Ottawa 3
Shenyang 3
Woodbridge 3
Fremont 2
Guangzhou 2
Marseille 2
Mestre 2
Modena 2
Munich 2
Norwalk 2
Pune 2
Tianjin 2
Carlentini 1
Casalgrande 1
Des Moines 1
Fayetteville 1
Frankfurt am Main 1
Fuzhou 1
Haikou 1
Hangzhou 1
Henderson 1
Jiaxing 1
Lanzhou 1
Leawood 1
London 1
Ningbo 1
Redwood City 1
Rio Saliceto 1
Rockville 1
San Mateo 1
Taiyuan 1
Taizhou 1
Verona 1
Vladikavkaz 1
Wenzhou 1
Xian 1
Zhengzhou 1
Totale 510
Nome #
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 99
Notch expression and bevacizumab efficacy in colorectal cancer patients 81
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 78
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 76
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 70
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 69
Immunotherapy options in metastatic renal cell cancer: Where we are and where we are going 50
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer 45
A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer 44
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: A case report 41
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen 35
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon α-2a as first-line endocrine treatments in advanced breast cancer: Updated results of a phase II, prospective, randomised multicentre trial 35
Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: Results of a phase II trial 35
Totale 758
Categoria #
all - tutte 3.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 6 18 7 2 4 23 0 0
2020/202135 3 1 1 1 4 3 1 7 6 2 5 1
2021/202256 2 0 0 5 2 0 12 2 1 3 4 25
2022/2023283 34 42 19 17 17 32 4 16 92 0 9 1
2023/2024111 0 13 1 1 5 50 11 5 3 3 10 9
2024/202596 12 14 23 30 17 0 0 0 0 0 0 0
Totale 758